Hard not to buy at this price. As mentioned yesterday, Current market cap surprisingly low. I follow the SP of some companies Ive previously invested in, one such being Genetic Signatures (GSS). As a comparison, Market cap double of BET, bleeding money each quarter, no growth over the past couple of years other than when Covid hit, Just received FDA approval for one of their products which is yet to hit the market. Cash receipts last quarter of $2.1 million yet lost $4,3 million overall with $20millionin the bank. Further dilution recently and banking all their hopes on a new product. BET losing less per quarter, really good growth prospects, and roughly same amount in the bank. Understandably, not much good feeling here due to the way the business was run previously, yet with new management and direction, this is way undervalued.
BET Price at posting:
8.2¢ Sentiment: Buy Disclosure: Held
